Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 87 points (-0.6%) at 14,874 as of Thursday, June 6, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 1,317 issues advancing vs. 1,603 declining with 125 unchanged. The Health Services industry currently sits down 0.59 versus the S&P 500, which is down 0.38. On the negative front, top decliners within the industry include ResMed ( RMD), down 3.57, and Becton Dickinson ( BDX), down 0.63. Top gainers within the industry include LifePoint Hospitals ( LPNT), up 3.6%, Tenet Healthcare ( THC), up 1.8%, Covance ( CVD), up 1.7%, Smith & Nephew ( SNN), up 1.3% and Fresenius Medical Care AG & Co. KGaA ( FMS), up 0.8%. TheStreet Ratings group would like to highlight 4 stocks pushing the industry lower today: 4. DENTSPLY International ( XRAY) is one of the companies pushing the Health Services industry lower today. As of noon trading, DENTSPLY International is down $0.56 (-1.4%) to $40.87 on light volume Thus far, 171,021 shares of DENTSPLY International exchanged hands as compared to its average daily volume of 766,200 shares. The stock has ranged in price between $40.75-$41.54 after having opened the day at $41.40 as compared to the previous trading day's close of $41.43. DENTSPLY International Inc. designs, develops, manufactures, and markets a range of consumable dental products for the professional dental market worldwide. DENTSPLY International has a market cap of $6.0 billion and is part of the health care sector. The company has a P/E ratio of 18.2, above the S&P 500 P/E ratio of 17.7. Shares are up 4.6% year to date as of the close of trading on Wednesday. Currently there are 6 analysts that rate DENTSPLY International a buy, 2 analysts rate it a sell, and 3 rate it a hold. TheStreet Ratings rates DENTSPLY International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, compelling growth in net income, reasonable valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full DENTSPLY International Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.